A gene signature-based computational framework for drug repurposing: Validation through identification of Amsacrine as a PLK1 inhibitor in aggressive breast cancer

Next research. 2026

View at publisher

Authors: Minh Tuan Nguyen

DOI: 10.1016/j.nexres.2026.101582

Cited by: 0

References: 40

Fields of Study & Subjects

Computational Drug Discovery Methods Breast Cancer Treatment Studies Gene expression and cancer classification

References 40